Testing colchicine plus coated aspirin to prevent heart events
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This Phase 3 study tests whether colchicine and a special type of aspirin can lower the risk of future heart attacks, strokes, or other major heart problems in people with type 2 diabetes who have not had a prior heart event. It aims to reduce cardiovascular risk using medicines that may calm inflammation and protect blood vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 55 to 80
- You have type 2 diabetes and are being treated for it
- You have not had a prior major heart event such as a heart attack or angina
- You have at least one extra heart-risk feature (like smoking, high inflammation, or abnormal cholesterol or artery-related findings)
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control during the study
- You can understand and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
This trial tests whether adding a targeted anti-inflammatory drug to standard care can prevent future heart attacks or strokes in people with high-risk chronic coronary artery disease. It is for people who have a moderate narrowing in a heart artery with a vulnerable plaque and signs of inflammation.
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
This trial tests whether taking colchicine can prevent coronary artery disease (heart artery blockages) in people who have several heart risk factors but do not already have diagnosed disease. It aims to see if colchicine lowers the chance of developing heart artery problems over time.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.